AT164885T
Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino aced sequence and vaccine containing same
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
148 members in 16 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 82310286 | United States of America | A | |
| 88714086 | United States of America | A | |
| 90288786 | United States of America | A | |
| 93310786 | United States of America | A |
Members148
| Document | Office | Kind | |
|---|---|---|---|
| IL79954D0 | Israel | D0 | |
| WO8701287A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU6371786A | Australia | A | |
| WO8704463A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7026687A | Australia | A | |
| EP0237546A1 | European Patent Office (EPO) | A1 | |
| EP0237546A4 | European Patent Office (EPO) | A4 | |
| US4716287A | United States of America | A | |
| FR2601689A1 | France | A1 | |
| EP0256092A1 | European Patent Office (EPO) | A1 | |
| JPS63501122A | Japan | A | |
| JPS63502482A | Japan | A | |
| WO8901040A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2308388A | Australia | A | |
| EP0332677A1 | European Patent Office (EPO) | A1 | |
| US4877737A | United States of America | A | |
| JPH02500409A | Japan | A | |
| EP0256092A4 | European Patent Office (EPO) | A4 | |
| EP0332677A4 | European Patent Office (EPO) | A4 | |
| US5047237A | United States of America | A | |
| US5068192A | United States of America | A | |
| AU1026692A | Australia | A | |
| AU623333B2 | Australia | B2 | |
| AU628294B2 | Australia | B2 | |
| FR2601689B1 | France | B1 | |
| CA2113641A1 | Canada | A1 | |
| WO9302104A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2393292A | Australia | A | |
| US5223424A | United States of America | A | |
| CA2137930A1 | Canada | A1 | |
| WO9325665A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4536293A | Australia | A | |
| CA2141422A1 | Canada | A1 | |
| WO9403628A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU4999193A | Australia | A | |
| EP0598759A1 | European Patent Office (EPO) | A1 | |
| AU656553B2 | Australia | B2 | |
| EP0644931A1 | European Patent Office (EPO) | A1 | |
| EP0654089A1 | European Patent Office (EPO) | A1 | |
| EP0658623A2 | European Patent Office (EPO) | A2 | |
| EP0332677B1 | European Patent Office (EPO) | B1 | |
| CA2182708A1 | Canada | A1 | |
| WO9521261A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1838895A | Australia | A | |
| CA2182880A1 | Canada | A1 | |
| DE3854190D1 | Germany | D1 | |
| WO9522607A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU1967195A | Australia | A | |
| CA1337120C | Canada | C | |
| EP0658623A3 | European Patent Office (EPO) | A3 | |
| JPH08500969A | Japan | A | |
| CA2196570A1 | Canada | A1 | |
| CA2626498A1 | Canada | A1 | |
| WO9605291A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3405395A | Australia | A | |
| DE3854190T2 | Germany | T2 | |
| US5506128A | United States of America | A | |
| AU672583B2 | Australia | B2 | |
| EP0745133A1 | European Patent Office (EPO) | A1 | |
| US5593873A | United States of America | A | |
| EP0754226A1 | European Patent Office (EPO) | A1 | |
| US5599544A | United States of America | A | |
| EP0644931A4 | European Patent Office (EPO) | A4 | |
| EP0654089A4 | European Patent Office (EPO) | A4 | |
| EP0776361A1 | European Patent Office (EPO) | A1 | |
| IL120169D0 | Israel | D0 | |
| MX9700833A | Mexico | A | |
| IL81398A | Israel | A | |
| EP0794257A1 | European Patent Office (EPO) | A1 | |
| CA1339468C | Canada | C | |
| AU683851B2 | Australia | B2 | |
| AU684046B2 | Australia | B2 | |
| US5731188A | United States of America | A | |
| EP0256092B1 | European Patent Office (EPO) | B1 | |
| AT164885TThis record | Austria | T | |
| US5741696A | United States of America | A | |
| DE3752182D1 | Germany | D1 | |
| EP0598759A4 | European Patent Office (EPO) | A4 | |
| US5763269A | United States of America | A | |
| JPH10506782A | Japan | A | |
| US5783195A | United States of America | A | |
| DE3752182T2 | Germany | T2 | |
| CA2283093A1 | Canada | A1 | |
| WO9837216A1 | World Intellectual Property Organization (WIPO) | A1 | |
| US5804372A | United States of America | A | |
| AU6334398A | Australia | A | |
| US5834305A | United States of America | A | |
| EP0745133A4 | European Patent Office (EPO) | A4 | |
| US5853733A | United States of America | A | |
| US5874279A | United States of America | A | |
| EP0754226A4 | European Patent Office (EPO) | A4 | |
| AU703321B2 | Australia | B2 | |
| JP2905483B2 | Japan | B2 | |
| US5928648A | United States of America | A | |
| US5961982A | United States of America | A | |
| US5965138A | United States of America | A | |
| AU711815B2 | Australia | B2 | |
| EP0973924A1 | European Patent Office (EPO) | A1 | |
| US6121043A | United States of America | A | |
| US6183753B1 | United States of America | B1 |
Showing 100 of 148
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent revokedRevokedRZN | RZN | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 87901222
Titles2
- German
- ABGESCHWÄCHTE HERPESVIREN, HERPESVIREN, DIE EINE FÜR AMINOSÄURESEQUENZEN KODIERENDE FREMD-DNS ENTHALTEN, SOWIE IMPFSTOFFE, DIE DIESE ENTHALTEN
- English
- Attenuated herpesviruses, herpesviruses, which contain a foreign DNA encoding amino acid sequences, and vesicles containing them
Classification
- CPC, 5
- C12N15/86
- A61K39/00
- C07K2319/02
- C12N2710/16743
- C12N2710/16762
- IPC, 8
- A61K39 00
- A61K39 245
- C07K14 015
- C07K14 05
- C07K14 14
- C12N15 86
- C12N15 869
- C12N7 01